Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:OBIO NASDAQ:PDEX NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.97-0.7%$2.16$0.76▼$3.00$112.32M1.4699,988 shs442,488 shsOBIOOrchestra BioMed$3.15+9.8%$2.64$2.20▼$6.50$121.73M0.6234,926 shs1.07 million shsPDEXPro-Dex$33.33-3.8%$39.40$26.28▼$70.26$109.32M-0.1133,440 shs27,440 shsRVPRetractable Technologies$0.97-5.4%$0.83$0.56▼$1.07$29.18M1.4564,244 shs127,944 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-0.67%+24.27%+50.76%+41.43%+149.58%OBIOOrchestra BioMed+9.76%+16.24%+20.69%+7.88%-37.00%PDEXPro-Dex-3.81%-2.06%-6.64%-25.95%+13.95%RVPRetractable Technologies-5.37%+13.60%+18.87%+45.91%+26.17%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.97-0.7%$2.16$0.76▼$3.00$112.32M1.4699,988 shs442,488 shsOBIOOrchestra BioMed$3.15+9.8%$2.64$2.20▼$6.50$121.73M0.6234,926 shs1.07 million shsPDEXPro-Dex$33.33-3.8%$39.40$26.28▼$70.26$109.32M-0.1133,440 shs27,440 shsRVPRetractable Technologies$0.97-5.4%$0.83$0.56▼$1.07$29.18M1.4564,244 shs127,944 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-0.67%+24.27%+50.76%+41.43%+149.58%OBIOOrchestra BioMed+9.76%+16.24%+20.69%+7.88%-37.00%PDEXPro-Dex-3.81%-2.06%-6.64%-25.95%+13.95%RVPRetractable Technologies-5.37%+13.60%+18.87%+45.91%+26.17%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.33HoldN/AN/AOBIOOrchestra BioMed 2.67Moderate Buy$13.50328.57% UpsidePDEXPro-Dex 2.50Moderate Buy$56.0068.02% UpsideRVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RVP, PDEX, APYX, and OBIO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025APYXApyx MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025OBIOOrchestra BioMedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025PDEXPro-DexWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)9/27/2025APYXApyx MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025OBIOOrchestra BioMedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025PDEXPro-DexWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)9/4/2025OBIOOrchestra BioMedHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $10.008/20/2025OBIOOrchestra BioMedBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Neutral8/13/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$20.008/7/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$20.00(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$48.10M2.34N/AN/A$0.38 per share7.82OBIOOrchestra BioMed$2.64M46.10N/AN/A$0.87 per share3.62PDEXPro-Dex$66.59M1.64$3.14 per share10.63$11.23 per share2.97RVPRetractable Technologies$38.16M0.76$0.02 per share48.25$3.31 per share0.29Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%11/14/2025 (Estimated)OBIOOrchestra BioMed-$61.02M-$1.83N/AN/AN/A-2,367.49%-289.42%-110.04%11/11/2025 (Estimated)PDEXPro-Dex$8.98M$2.7012.3416.18N/A13.48%26.67%14.95%10/30/2025 (Estimated)RVPRetractable Technologies-$7.01M-$0.29N/A∞N/A-41.11%-17.15%-9.33%N/ALatest RVP, PDEX, APYX, and OBIO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/30/2025Q1 2026PDEXPro-Dex$0.50N/AN/AN/A$15.30 millionN/A9/4/2025Q4 2025PDEXPro-Dex$0.47$0.36-$0.11$0.36$17.90 million$17.49 million8/12/2025Q2 2025OBIOOrchestra BioMed-$0.51-$0.50+$0.01-$0.50$0.78 million$0.84 million8/7/2025Q2 2025APYXApyx Medical-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AOBIOOrchestra BioMedN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical4.614.723.95OBIOOrchestra BioMed48.762.102.09PDEXPro-Dex0.253.231.71RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%OBIOOrchestra BioMed53.20%PDEXPro-Dex15.28%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%OBIOOrchestra BioMed8.10%PDEXPro-Dex47.50%RVPRetractable Technologies57.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.82 million32.07 millionOptionableOBIOOrchestra BioMed438.64 million35.51 millionNot OptionablePDEXPro-Dex1403.28 million1.72 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableRVP, PDEX, APYX, and OBIO HeadlinesRecent News About These CompaniesRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Buys 30,000 SharesOctober 10 at 6:09 AM | insidertrades.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersSeptember 30, 2025 | businesswire.comThomas Shaw Purchases 17,500 Shares of Retractable Technologies (NYSE:RVP) StockSeptember 26, 2025 | insidertrades.comRetractable Technologies Stock Gains Following Q2 Earnings GrowthAugust 21, 2025 | zacks.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 32,935 Shares of StockAugust 20, 2025 | insidertrades.comRetractable Technologies Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comRetractable Technologies, Inc. Results for the Periods Ended June 30, 2025August 14, 2025 | businesswire.comRetractable Technologies, Inc. (NYSE:RVP) CEO Purchases $37,155.75 in StockAugust 12, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $20,193.12 in StockAugust 1, 2025 | insidertrades.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce | RVP Stock NewsJuly 23, 2025 | gurufocus.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing WorkforceJuly 23, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Business WireJuly 2, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersJune 30, 2025 | businesswire.comRetractable technologies CEO Shaw buys $14,274 in RVP stockJune 20, 2025 | investing.comZacks Initiates Coverage of Retractable Technologies With Underperform RecommendationJune 19, 2025 | zacks.comRetractable Technologies, Inc. (NYSE:RVP) CEO Buys $14,313.42 in StockJune 19, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $13,047.54 in StockJune 17, 2025 | insidertrades.comretractable technologies appoints new auditor after mergerJune 8, 2025 | investing.comThomas J. Shaw Buys 86,014 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockMay 17, 2025 | insidertrades.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025 | RVP Stock NewsMay 15, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRVP, PDEX, APYX, and OBIO Company DescriptionsApyx Medical NASDAQ:APYX$2.97 -0.02 (-0.67%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$2.88 -0.09 (-3.03%) As of 10/10/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Orchestra BioMed NASDAQ:OBIO$3.15 +0.28 (+9.76%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$3.08 -0.07 (-2.22%) As of 10/10/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.Pro-Dex NASDAQ:PDEX$33.33 -1.32 (-3.81%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$33.08 -0.24 (-0.74%) As of 10/10/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Retractable Technologies NYSE:RVP$0.97 -0.06 (-5.37%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$0.98 +0.01 (+0.65%) As of 10/10/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Bassett Furniture: Buy Now, Sit Back, and Collect Dividends Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom How Gamers Are Powering Microsoft’s Next Wave of Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
